COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States.It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression. The company was formerly known as COMPASS Rx Limited.
